XML 23 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
SEGMENT INFORMATION
 9 Months Ended
Jun. 30, 2017
Segment Reporting [Abstract]  
SEGMENT INFORMATION
6.
SEGMENT INFORMATION
 
We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to Consolidated Financial Statements in our annual report on Form 10-K for the year ended September 30, 2016.
 
 
 
Three Months Ended
 
Nine Months Ended
 
 
 
June 30,
 
June 30,
 
 
 
2017
 
2016
 
2017
 
2016
 
 
 
 
 
 
 
 
 
 
 
Revenue:
 
 
 
 
 
 
 
 
 
 
 
 
 
Service
 
$
4,954
 
$
3,773
 
$
15,180
 
$
11,881
 
Product
 
 
882
 
 
1,280
 
 
3,189
 
 
3,406
 
 
 
$
5,836
 
$
5,053
 
$
18,369
 
$
15,287
 
Operating income (loss):
 
 
 
 
 
 
 
 
 
 
 
 
 
Service
 
$
512
 
$
(364)
 
$
1,253
 
$
(962)
 
Product
 
 
(175)
 
 
(1)
 
 
(267)
 
 
(194)
 
 
 
$
337
 
$
(365)
 
$
986
 
$
(1,156)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
 
(112)
 
 
(107)
 
 
(322)
 
 
(243)
 
Decrease in fair value of warrant
 liability
 
 
—
 
 
21
 
 
—
 
 
189
 
Other income
 
 
2
 
 
1
 
 
4
 
 
2
 
Income (loss) before income taxes
 
$
227
 
$
(450)
 
$
668
 
$
(1,208)